Leiden University Medical Center and Intravacc to Start Clinical Trial with New Intranasal Corona Vaccine
Nasal spray vaccine based on soluble nano-spheres with synthetic corona proteinsNo use of mRNA or vector technologyBetter and direct immunization of mucosa against multiple corona virusesIntravacc focuses
Source: finanznachrichten.de